Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
329.00    -6.40 (-1.91%)
Bid:
325.20
Ask:
327.80
Spread: 2.60 (0.80%)
Market Cap: £720.74m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Final Results

23 Mar 2016 07:00

RNS Number : 9694S
Burford Capital
23 March 2016
 

23 March 2016

 

BURFORD CAPITAL DELIVERS 27% GROWTH IN 2015 OPERATING PROFIT

 

82% increase in income from litigation finance

 

Burford Capital Limited ("Burford" or "the Company"), a leading global finance firm focused on law, announces its financial results for the year ended 31 December 2015.

 

Highlights

 

· Income increased by 26% to a record $103.0 million (2014: $82 million)

 

· Driven by 82% increase in income from litigation-related investments to $86.9 million (2014: $47.8 million)

 

· 27% increase in operating profit to $77.2 million (2014: $60.7 million) and 21% increase in profit after tax to $65.7 million (2014: $54.2 million), contributing to a 16% ROE

 

· Strong growth in earnings per share, up 42% to 32¢ (2014: 22¢), supporting 14% increase in total dividend to 8.0¢ (2014: 7.0¢); dividend payable on 17 June 2016 with record date of 27 May 2016

 

· Cumulative net return on invested capital for concluded investments rises to 70% (2014: 60%), for an IRR of 28% (2014: 24%)

 

· Persistent high demand for Burford's capital reflected in record new investment commitments of $206 million, up 35% on 2014, sowing seeds for future profits

 

· Current investment portfolio stands above $627 million in commitments, across 54 different litigation investments (including $100 million portfolio investment in early 2016)

 

· Strong organic cash generation, with $140 million in cash produced in 2015, more than double prior year

 

Sir Peter Middleton, Chairman of Burford, commented:

 

"We have experienced rapid growth over our six year history and 2015 was no exception. Our results continue to demonstrate the fundamentally uncorrelated nature of Burford's business and our ability to generate cash from litigation finance investments without regard to economic or market conditions."

 

Christopher Bogart, Chief Executive Officer of Burford, added:

 

"We are delighted to record income of over $100 million for the first time, a milestone reflecting continued strong growth in the diversifying worldwide litigation financing market, as well as our ongoing flexibility in meeting our clients' needs. We see further opportunities to grow, while sustaining underwriting discipline and targeting attractive risk adjusted returns."

 

Financial Summary

 

A financial summary is set out below. Burford's complete annual report and audited accounts are available at http://www.rns-pdf.londonstockexchange.com/rns/9694S_1-2016-3-22.pdf or from the Burford website: www.burfordcapital.com/investor-relations/.

 

2015

2014

% change

$'000

$'000

Litigation investment income

86,903

47,847

82%

Insurance income

12,763

24,338

(48%)

New initiatives income

3,484

222

Other income

(143)

9,627

Total Income

103,007

82,034

26%

Operating expenses - litigation investment

(13,953)

(10,416)

Operating expenses - insurance

(2,577)

(5,396)

Operating expenses - new initiatives

(4,498)

(1,561)

Operating expenses - corporate

(4,812)

(3,950)

Operating profit

77,167

60,711

27%

Finance costs

(9,290)

(3,652)

Profit before tax

67,877

57,059*

19%

Total taxation

(2,204)

(2,906)*

Profit after tax

65,673

54,153*

21%

* Profit before tax, taxation and profit after tax in 2014 do not include the amortisation, and related deferred taxation credit, of the embedded value intangible asset, which is included in the prior period figures in the Consolidated Statement of Comprehensive Income on page 25 of Burford's Annual Report 2015

 

Investor and Analyst Conference Call

 

Burford will host a conference call for investors and analysts at 10:00am (GMT) / 06:00am (EDT) on Wednesday 23 March 2016. The dial-in number for the conference call is +44 (0) 203 003 2666 / +1 212 999 6659 and the password is 'Burford'.

 

An accompanying presentation will be available on the Burford Capital website:

www.burfordcapital.com/investor-relations/

 

A replay facility will be available until Wednesday 6 April 2016 by dialling +44 (0) 20 8196 1998 / +1 866 583 1035 with the passcode '8679266#'.

 

 

Burford's indirect subsidiary, Burford Capital PLC, has also today issued an RNS concerning an intention to hold investor meetings to gauge demand for a possible issue of sterling bonds, which is available at RNS announcement 9699S [Burford Capital PLC - Intention to hold meetings re possible bond issue] or from the Burford website: www.burfordcapital.com/investor-relations/bonds/

 

For further information, please contact:

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Ken Fleming +44 (0)20 3037 2000

Nicholas Harland

 

Haitong Securities (UK) Limited - Joint Broker

John Riddell +44 (0)20 7456 9191

Harry Stockdale

 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0)20 7653 4000

 

Neustria Partners - Financial Communications for Burford Capital

Robert Bailhache +44 (0)20 3021 2580

robert.bailhache@neustriapartners.com

 

About Burford Capital

 

Burford is a leading global finance firm focused on law. Our businesses include litigation finance, insurance and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. Burford's equity and debt securities are publicly traded on the London Stock Exchange. We work with lawyers and clients around the world from our principal offices in New York and London.

 

For more information about Burford, visit www.burfordcapital.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PGUUCWUPQPWP
Date   Source Headline
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering
7th Jul 202512:57 pmRNSPrivate Offering of Senior Notes
3rd Jul 202511:00 amRNSIssue of New Shares in Connection With LTIP
2nd Jul 20255:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.